D😉Cpharma

[D😉Cpharma @the_docmba]

It’s interesting that even kids are picking up on how broken our healthcare system is. The capacity and the way to do things has to change.

This incoming Junior in a high school interviewed physicians at a conference this is what he found 👀

https://t.co/fyBbt13y1v

[D😉Cpharma @the_docmba]

@DGlaucomflecken hearing the same things again and wondering if and when the system will change for the patients.

[D😉Cpharma @the_docmba]

It’s interesting that even kids are picking up on how broken our healthcare system is. The capacity and the way to do things has to change.

This incoming Junior in a high school interviewed physicians at a conference this is what he found 👀

https://t.co/fyBbt13y1v

[D😉Cpharma @the_docmba]

@adamfeuerstein Depends on who you ask!

[D😉Cpharma @the_docmba]

@VivekSubbiah @MiamiCancerInst @BaptistHealthSF @BrainTumorDoc @PGrivasMDPhD @chadinabhan @VenurVyshak @weldeiry Great to see a few known faces. @BrainTumorDoc congrats on this great initiative.

[Yungan TAO @YG_TAO]

Excited to share the final publication in The Lancet of our phase 3 GORTEC 2018-01 (NIVOPOST-OP) trial results. We hope these results will support changes in clinical practice and future guideline updates. @PBlanchardMD @DrMLChua @GorphePhilippe https://t.co/TpPrhMkbOs

[D😉Cpharma @the_docmba]

#NewProfilePic

[Biotech Investor @learnbiotech]

Drug launches are hard, especially for companies with no experience. Yet its becoming more common

First timers underperform expectations vs experienced peers ~75% vs ~55% of the time

@McKinsey correlates this to greater & earlier commercial investment from exper.

Do you agree?

[D😉Cpharma @the_docmba]

@dieworkwear On the contrary I find them much better!!!!

[Jacob Plieth @JacobPlieth]

It's war in Kras! $RHHBY starts pivotal Krascendo-1 trial head to head vs $AMGN & $BMY. Via @ApexOnco -> https://t.co/PzsPuie0l8 $LLY $MRK

[D😉Cpharma @the_docmba]

@Biotech2k1 I follow you religiously

[D😉Cpharma @the_docmba]

@skathire I had the pleasure of working on them at Novo when they were in phase 2 and now it’s great to see this progress

[PečhuLaaŁ™ @PechuLaaL]

No Drama, No VFX, No Sound Effects, No Screaming. The kind of pure reporting & journalism we need.

#BalasoreTrainAccident

[D😉Cpharma @the_docmba]

Thatis something my grandmother used to teach us more than 40 years back. Part of Indian culture since ages…

[TIME @TIME]

"Sitting on the floor with your legs crossed is one of the ten healthy habits we advocate for in our new book Built to Move," write Kelly Starrett and Julia Starrett https://t.co/KT7hQ7CLXq

[D😉Cpharma @the_docmba]

USA vs. Japan vs. India | Watch Till End 🤣 | #shorts #shortsfeed #shorts... https://t.co/GmOILzzOeI via @YouTube

[Scott Gottlieb, MD 🇺🇸 @ScottGottliebMD]

Good overview from Nature on T cell therapies. The ability to engineer T cells is transforming the treatment of cancer and will soon impact other fields of medicine. More than 500 clinical trials are under way and adjacent approaches are moving to clinic.

https://t.co/nA5CESECzR

[D😉Cpharma @the_docmba]

@bradloncar @ADaviesDHCG Phenomenal discussion… covered all the key areas and in a very simplistic way.

[D😉Cpharma @the_docmba]

@LGlimcherMD @DanaFarber It’s stories like these that folks like me feel inspired by every single day as we work in Pharma.

[Brian Wallach @bsw5020]

Favor to ask: can you please retweet the tweet below so that the world can hear it and see a person with ALS.

Some call me strong. I call myself lucky. I have had time that most ALS patients don’t get.

Let’s change that, together.

[D😉Cpharma @the_docmba]

When bread is Cool! Can anyone name this?